![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- ACOG. ACOG Practice Bulletin 10: Induction of labor. American College of Obstetricians and Gynaecologists, Washington, DC 1999
- British National Formulary. BNF. British Medical Association and Royal Pharmaceutical Society of Great Britain, London 2006
- Calder A A, MacKenzie I Z. Review of Propess – a controlled release dinoprostone (prostaglandin E2) pessary. Journal of Obstetrics and Gynaecology 1997; 17(Suppl 2)S53–S67
- Chyu J K, Strassner H T. Prostaglandin E2 for cervical ripening: a randomized comparison of Cervidil versus Prepidil. American Journal of Obstetrics and Gynecology 1997; 177: 606–611
- Crane J, Leduc L, Farine D, Hodges S, Reid G J, Van Aerde J. Induction of labour at term – SOGC Clinical practice guideline. Journal of Obstetrics and Gynaecology Canada 2001; 23: 717–741
- Crane J M, Bennett K A. A meta-analysis of controlled-release prostaglandin for cervical ripening and labour induction. Journal of the Society of Obstetricians and Gynaecologists of Canada 2000; 22: 692–698
- Crowley P. Interventions for preventing or improving the outcome of delivery at or beyond term. Cochrane Database System Reviews 2006; 4: CD000170
- Hilder L, Costeloe K, Thilaganathan B. Prolonged pregnancy: evaluating gestation-specific risks of fetal and infant mortality. British Journal of Obstetrics and Gynaecology 1998; 105: 169–173
- Hofmeyr G J. Induction of labour with an unfavourable cervix. Best Practice and Research Clinical Obstetrics and Gynaecology 2003; 17: 777–794
- Kelly A J, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database System Reviews 2003; 4: CD003101
- MacKenzie I Z, McKinlay E. Paediatric follow-up study: Follow-up of infants delivered by spontaneous vaginal delivery, following prostaglandin E2 or oxytocin induction, or by caesarean section. Propess-RS – A clinical review, A A Calder, M JNC Keirse, I Z MacKenzie. Euromed, Haslemere 1995; 37–39
- Ottinger W S, Menard M K, Brost B C. A randomized clinical trial of prostaglandin E2 intracervical gel and a slow release vaginal pessary for preinduction cervical ripening. American Journal of Obstetrics and Gynecology 1998; 179: 349–353
- Rayburn W F, Wapner R J, Barss V A, Spitzberg E, Molina R D, Mandsager N, et al. An intravaginal controlled-release prostaglandin E2 pessary for cervical ripening and initiation of labor at term. Obstetrics and Gynecology 1992; 79: 374–379
- Rayburn W F, Zhang J. Rising rates of labor induction: present concerns and future strategies. Obstetrics and Gynecology 2002; 100: 164–167
- RCOG. Evidence-based Clinical Guideline 9: Induction of labour. Royal College of Obstetricians and Gynaecologists, London 2001
- Vollebregt A, van't Hof D B, Exalto N. Prepidil compared to Propess for cervical ripening. European Journal of Obstetrics, Gynecology and Reproductive Biology 2002; 104: 116–119
- Witter F R, Mercer B M. Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2 insert Study Group. Journal of Maternal-Fetal Medicine 1996; 5: 64–69
- Witter F R, Rocco L E, Johnson T R. A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. American Journal of Obstetrics and Gynecology 1992; 166: 830–834
- Zhang J, Yancey M K, Henderson C E. U.S. national trends in labor induction, 1989–1998. Journal of Reproductive Medicine 2002; 47: 120–124